| Bioactivity | Glucokinase activator 3 is a potent and full Glucokinase (GK) activator with an AC50 of 38 nM. Glucokinase activator 3 has the potential for the research of type 2 diabetes[1]. | ||||||||||||
| Target | AC50: 38 nM (GK) | ||||||||||||
| Name | Glucokinase activator 3 | ||||||||||||
| CAS | 1001417-92-0 | ||||||||||||
| Formula | C26H33N2O9PS2 | ||||||||||||
| Molar Mass | 612.65 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Shi Y, et al. Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132). J Med Chem. 2022, 65(5):4291-4317. |